Life Scientist > Life Sciences

Norwood in lucrative deal with US pharma

11 November, 2003 by Melissa Trudinger

Norwood Abbey (ASX: NAL) has entered into a lucrative deal with TAP Pharmaceuticals, giving the US-based company an exclusive license to commercialise its immunology intellectual property in the US market.


Primitive microbe lends a hand to high-tech crime fight

07 November, 2003 by Graeme O'Neill

A steaming, sulphurous spring in the caldera of the world's coldest, most isolated volcano has yielded a powerful new forensic tool that will make it even tougher for criminals to evade the law.


Stem cell research: Retinal cells could be first to clinic

31 October, 2003 by Melissa Trudinger

Retinal stem cells could well be the first neural stem cells used in patients, University of Toronto researcher Derek van der Kooy predicted recently at the National Stem Cell Centre conference in Melbourne.


Stem cell research: Turning sugar into bone

31 October, 2003 by Melissa Trudinger

University of Queensland scientist Assoc Prof Victor Nurcombe has moved to Singapore to continue his work on repairing bone fractures using sugars from the surface of cells.


Stem cell research: the big task ahead

31 October, 2003 by Melissa Trudinger

In his closing comments to the National Stem Cell Centre conference in Melbourne earlier this month, Monash University's Martin Pera gave voice to a thought many of the scientists at the conference had been contemplating over the previous couple of days. "What is in front of us is of the scale of the Human Genome Project, if not larger," Pera told delegates. "In the last five years the ethical frameworks have been established. But we have to continue the ethical debate."


Kidney stem cell project launched

31 October, 2003 by Melissa Trudinger

An ambitious project is underway in Australia to define and isolate renal stem cells so that they can be used to either repair or regenerate a kidney.


Melbourne trial uses adult stem cells to treat severe angina

09 October, 2003 by Melissa Trudinger

Bone marrow stem cells have been used to treat five patients with severe angina in a Phase I clinical trial at St Vincent's Hospital in Melbourne.


Circadian boosts neuroscience investment

09 October, 2003 by Tanya Hollis

Circadian Technologies (ASX:CIR) has added another string to its neuroscience bow with an investment in new Melbourne research.


Feds let CSL supply deal lapse

04 September, 2003 by Melissa Trudinger

The federal government made a decision more than a year ago not to take up an option to extend its contract with CSL for the supply of blood plasma products to Australian hospitals for another five years.


Ross River study offers arthritis clues

28 August, 2003 by Graeme O'Neill

Hundreds of Australians have endured misery and debilitating arthritic pain in the joints after being infected by mosquito-borne Ross River Virus. The symptoms can last for months, and recovered patients can relapse years later.


New neuro facility establishes clincial trials program

14 August, 2003 by Melissa Trudinger

A clinical trials program for neuroscience is being established as a platform by the National Neuroscience Facility (NNF) to encourage greater involvement of Australian neuroscience researchers and clinicians in industry-sponsored and investigator driven clinical studies.


$42.5m neuroscience facility opens

13 August, 2003 by Melissa Trudinger

Brain and mind disorders, watch out -- Australia's neuroscience researchers are coming after you.


National Neuroscience Facility opens for business

08 August, 2003 by Melissa Trudinger

Cooperative competition -- or 'coopetition' -- was the name of the game last night at the launch of the AUD$18 million National Neuroscience Facility in Melbourne.


US paper man boosts Genesis NZ

07 August, 2003 by Jeremy Torr

New Zealand biotech Genesis Research and Development has successfully lured an ex-US heavyweight to head up its increased push into the plant biotech arena.


Trounson hasn't resigned: NSCC

05 August, 2003 by Iain Scott

Prof Alan Trounson has not resigned from the National Stem Cell Centre, contrary to a report in today's The Australian newspaper.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd